맞춤형 항체 시장 규모는 향후 수년간 급성장할 것으로 예측됩니다. 2029년에는 CAGR 13.3%로 성장할 전망이며, 7억 8,000만 달러로 성장이 예측됩니다. 예측 기간 동안의 성장은 표적면역요법의 채택 증가, 바이오 의약품에 대한 투자 증가, 신경변성 질환 유병률 증가, 체외진단약(IVD) 용도 수요 확대, 헬스케어 지출 증가에 기인할 것으로 보입니다. 예측 기간 주요 동향으로는 맞춤형 의료 대두, 항체 공학 기술 진보, 바이오 기술 및 유전자 공학의 진보, 치료 용도 확대, 항체 정제 기술의 혁신 등을 들 수 있습니다.
맞춤형 의료에 대한 수요 증가는 향후 수년간 맞춤형 항체 시장의 확대를 견인할 것으로 예측됩니다. 맞춤형 의료는 개인의 유전적 체질, 라이프 스타일, 환경 요인에 근거해 치료나 예방 전략을 조정하는 의료 접근법입니다. 맞춤형 의료에 대한 수요의 고조는 유전체학 진보, 바이오마커에 기초한 치료법의 이용 가능성 확대, 부작용을 최소화하면서 유효성을 높이는 맞춤형 치료 옵션에 대한 소비자 기호 고조에 의해 뒷받침되고 있습니다. 맞춤형 항체는 맞춤형 치료 전략을 위한 질환 검출, 치료 표적, 바이오마커 동정을 개선하는 특이성이 높은 면역 시약을 제공함으로써 맞춤형 의료를 지원합니다. 예를 들어 2024년 2월 미국 비영리단체인 개별화의료연합(Personalized Medicine Coalition)은 2023년 식품의약국(FDA)이 희귀질환 환자를 위해 16개의 새로운 개별화 치료를 승인해 2022년 6개에서 증가했다고 보고했습니다. 그 결과 개별화 의료에 대한 수요의 증대가 맞춤형 항체 시장의 성장을 견인하고 있습니다.
맞춤형 항체 시장의 주요 기업은 항체 탐색을 강화하고 특이성을 향상시키며 시장 개척 프로세스를 가속화하기 위해 인공지능과 같은 첨단 기술의 통합을 점점 더 진행하고 있습니다. 인공지능은 항원 선택의 정교화, 항체-항원 상호작용의 예측, 머신러닝을 이용한 후보 스크리닝 합리화를 통해 맞춤형 항체 개발을 지원하며, 궁극적으로는 바이오의약품 연구의 신속화 및 비용 효율 향상으로 이어집니다. 예를 들면, 2024년 10월, 미국의 생명공학 기업인 Archon Biosciences Inc.는, 2,000만 달러의 자금을 들여, 기존의 항체를 치료 용도로 커스터마이징하는 것을 가능하게 하는, 계산에 의해 설계된 항체 케이지의 개발을 시작했습니다. Archon사의 독자 기술은 항체를 케이지 구조로 조립함으로써 코어 구조를 바꾸지 않고 항체의 특성을 변경할 수 있게 합니다. 이 기술 혁신은 치료 표적에 대한 항체의 친화성을 높이는 동시에 표적 외 상호작용을 저감하고 유효성과 안전성을 모두 개선하도록 설계되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장-거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
- 세계의 맞춤형 항체 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
- 최종 이용 산업의 분석
- 세계의 맞춤형 항체 시장 : 성장률 분석
- 세계의 맞춤형 항체 시장 실적 : 규모 및 성장(2019-2024년)
- 세계의 맞춤형 항체 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
- 세계의 맞춤형 항체 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 맞춤형 항체 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 단일클론 항체
- 폴리클로날 항체
- 재조합 항체
- 기타 유형
- 세계의 맞춤형 항체 시장 : 서비스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 항체 개발
- 항체 생산 및 정제
- 항체 단편화 및 표지
- 세계의 맞춤형 항체 시장 : 소스별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 쥐
- 토끼
- 기타 정보원
- 세계의 맞춤형 항체 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 종양학
- 감염증
- 신경학
- 줄기세포
- 면역학
- 심혈관 질환
- 기타 용도
- 세계의 맞춤형 항체 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 제약 및 생명 공학 기업
- 학술연구기관
- 계약연구기관
- 병원 및 진료소
- 세계의 맞춤형 항체 시장 : 단일클론 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 쥐 단일클론항체
- 키메라 단일클론항체
- 인간화 단일클론항체
- 완전 인간 단일클론항체
- 세계의 맞춤형 항체 시장 : 폴리클로날 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 토끼 폴리클로날 항체
- 염소 폴리클로날 항체
- 양 폴리클로날 항체
- 기타 동물 유래 폴리클로날 항체
- 세계의 맞춤형 항체 시장 : 재조합 항체 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 단쇄 가변 단편(scFv)
- 나노 바디
- 이중특이적 항체
- 항체 단편
- 세계의 맞춤형 항체 시장 : 기타 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 앱타머
- 나노 바디(낙타과 동물의 항체)
- 하이브리도마
제7장 지역별 및 국가별 분석
- 세계의 맞춤형 항체 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
- 세계의 맞춤형 항체 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
- 맞춤형 항체 시장 : 경쟁 구도
- 맞춤형 항체 시장 : 기업 프로파일
- Merck & Co. Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Thermo Fisher Scientific Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Agilent Technologies Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Lonza Group AG 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Bio-Rad Laboratories Inc.
- Bio-Techne Corporation
- GenScript Biotech Corporation
- BioLegend Inc.
- Abcam plc
- Cusabio Biotech Co. Ltd.
- OriGene Technologies Inc.
- Cell Signaling Technology Inc.
- Abgent Inc.
- ProSci Incorporated
- Santa Cruz Biotechnology Inc.
- Rockland Immunochemicals Inc.
- Creative Biolabs Inc.
- Novus Biologicals LLC
- Creative Diagnostics Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
- 맞춤형 항체 시장(2029년) : 새로운 기회를 제공하는 국가
- 맞춤형 항체 시장(2029년) : 새로운 기회를 제공하는 부문
- 맞춤형 항체 시장(2029년) : 성장 전략
제36장 부록
AJY
A custom antibody is a laboratory-engineered antibody specifically developed to target a particular antigen of interest. These antibodies are designed for research, diagnostic, or therapeutic purposes, catering to the unique requirements of scientists and healthcare professionals. Custom antibodies play a crucial role in biomedical research, diagnostics, and drug development, enabling precise detection and targeting of biomolecules.
The primary types of custom antibodies include monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and other variants. Monoclonal antibodies are lab-created molecules that precisely target a specific antigen, mimicking the immune system's natural pathogen-fighting mechanism. Services in this market encompass antibody development, production and purification, as well as fragmentation and labeling. The sources of custom antibodies include mice, rabbits, and other organisms. These antibodies are utilized in various fields such as oncology, infectious diseases, neurology, stem cell research, immunology, and cardiovascular diseases. The key end users of custom antibodies include pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations, and hospitals and clinics.
The custom antibody market research report is one of a series of new reports from The Business Research Company that provides custom antibody market statistics, including the custom antibody industry global market size, regional shares, competitors with the custom antibody market share, detailed custom antibody market segments, market trends, and opportunities, and any further data you may need to thrive in the custom antibody industry. This custom antibody market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The custom antibody market size has grown rapidly in recent years. It will grow from $0.42 billion in 2024 to $0.47 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth during the historic period can be attributed to the rising demand for custom antibodies, the expanding use of precision medicine, the increasing prevalence of chronic diseases and cancer, the surge in research and development activities, and the growing number of clinical trials.
The custom antibody market size is expected to see rapid growth in the next few years. It will grow to $0.78 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth during the forecast period can be attributed to the increasing adoption of targeted immunotherapy, rising investment in biopharmaceuticals, the growing prevalence of neurodegenerative diseases, the expanding demand for in vitro diagnostics (IVD) applications, and rising healthcare expenditures. Key trends in the forecast period include the rise of personalized medicine, technological advancements in antibody engineering, progress in biotechnology and genetic engineering, expanding therapeutic applications, and innovations in antibody purification techniques.
The increasing demand for personalized medicine is anticipated to drive the expansion of the custom antibody market in the coming years. Personalized medicine is a medical approach that tailors treatment and prevention strategies based on an individual's genetic makeup, lifestyle, and environmental factors. The rising demand for personalized medicine is fueled by advancements in genomics, the growing availability of biomarker-based therapies, and a heightened consumer preference for customized treatment options that enhance efficacy while minimizing adverse effects. Custom antibodies support personalized medicine by providing highly specific immune reagents that improve disease detection, therapeutic targeting, and biomarker identification for individualized treatment strategies. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients, up from six in 2022. As a result, the increasing demand for personalized medicine is driving the growth of the custom antibody market.
Leading companies in the custom antibody market are increasingly integrating advanced technologies such as artificial intelligence to enhance antibody discovery, improve specificity, and accelerate development processes. Artificial intelligence aids custom antibody development by refining antigen selection, predicting antibody-antigen interactions, and streamlining candidate screening using machine learning, ultimately leading to faster and more cost-effective biopharmaceutical research. For instance, in October 2024, Archon Biosciences Inc., a US-based biotechnology company, launched with $20 million in funding to develop computationally designed antibody cages that enable the customization of existing antibodies for therapeutic applications. Archon's proprietary technology assembles antibodies into cage structures, allowing modifications to their properties without altering their core structures. This innovation is designed to enhance antibody affinity for therapeutic targets while reducing off-target interactions, improving both efficacy and safety.
In September 2024, Leinco Technologies Inc., a US-based biotechnology company, acquired QED Biosciences Inc. for an undisclosed amount. This acquisition is intended to support Leinco Technologies' strategic growth by expanding its market presence and strengthening its offerings in the life sciences and IVD raw material sectors. QED Bioscience Inc., also a US-based biotechnology company, specializes in the design and production of custom antibodies.
Major players in the custom antibody market are Merck & Co. Inc., AbbVie Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, GenScript Biotech Corporation, BioLegend Inc., Abcam plc, Cusabio Biotech Co. Ltd., OriGene Technologies Inc., Cell Signaling Technology Inc., Abgent Inc., ProSci Incorporated, Santa Cruz Biotechnology Inc., Rockland Immunochemicals Inc., Creative Biolabs Inc., Novus Biologicals LLC, Creative Diagnostics Inc., Biorbyt Ltd., BIOTEM SAS, Capra Biosciences Inc., Pacific Immunology Inc., ProteoGenix SAS.
North America was the largest region in the custom antibody market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in custom antibody report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the custom antibody market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The custom antibody market consists of revenues earned by entities by providing services such as antibody production, antibody purification, and conjugation. The market value includes the value of related goods sold by the service provider or included within the service offering. The custom antibody market also consists of sales of products including antibody fragments, conjugated antibodies, and secondary antibodies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Custom Antibody Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on custom antibody market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for custom antibody ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The custom antibody market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Monoclonal Antibodies; Polyclonal Antibodies; Recombinant Antibodies; Other Types
- 2) By Service: Antibody Development; Antibody Production And Purification; Antibody Fragmentation And Labeling
- 3) By Source: Mice; Rabbit; Other Sources
- 4) By Application: Oncology; Infectious Diseases; Neurology; Stem Cells; Immunology; Cardiovascular Diseases; Other Applications
- 5) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organization; Hospitals And Clinics
- Subsegments:
- 1) By Monoclonal Antibodies: Murine Monoclonal Antibodies; Chimeric Monoclonal Antibodies; Humanized Monoclonal Antibodies; Fully Human Monoclonal Antibodies
- 2) By Polyclonal Antibodies: Rabbit Polyclonal Antibodies; Goat Polyclonal Antibodies; Sheep Polyclonal Antibodies; Other Animal-Derived Polyclonal Antibodies
- 3) By Recombinant Antibodies: Single-Chain Variable Fragment (scFv); Nanobodies; Bispecific Antibodies; Antibody Fragments
- 4) By Other Types: Aptamers; Nanobodies (Camelid Antibodies); Hybridomas
- Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Lonza Group AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Custom Antibody Market Characteristics
3. Custom Antibody Market Trends And Strategies
4. Custom Antibody Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Custom Antibody Growth Analysis And Strategic Analysis Framework
- 5.1. Global Custom Antibody PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Custom Antibody Market Growth Rate Analysis
- 5.4. Global Custom Antibody Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Custom Antibody Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Custom Antibody Total Addressable Market (TAM)
6. Custom Antibody Market Segmentation
- 6.1. Global Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Other Types
- 6.2. Global Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antibody Development
- Antibody Production And Purification
- Antibody Fragmentation And Labeling
- 6.3. Global Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Mice
- Rabbit
- Other Sources
- 6.4. Global Custom Antibody Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oncology
- Infectious Diseases
- Neurology
- Stem Cells
- Immunology
- Cardiovascular Diseases
- Other Applications
- 6.5. Global Custom Antibody Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceutical And Biotechnology Companies
- Academic And Research Institutes
- Contract Research Organization
- Hospitals And Clinics
- 6.6. Global Custom Antibody Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Murine Monoclonal Antibodies
- Chimeric Monoclonal Antibodies
- Humanized Monoclonal Antibodies
- Fully Human Monoclonal Antibodies
- 6.7. Global Custom Antibody Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Rabbit Polyclonal Antibodies
- Goat Polyclonal Antibodies
- Sheep Polyclonal Antibodies
- Other Animal-Derived Polyclonal Antibodies
- 6.8. Global Custom Antibody Market, Sub-Segmentation Of Recombinant Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Single-Chain Variable Fragment (scFv)
- Nanobodies
- Bispecific Antibodies
- Antibody Fragments
- 6.9. Global Custom Antibody Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Aptamers
- Nanobodies (Camelid Antibodies)
- Hybridomas
7. Custom Antibody Market Regional And Country Analysis
- 7.1. Global Custom Antibody Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Custom Antibody Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Custom Antibody Market
- 8.1. Asia-Pacific Custom Antibody Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Custom Antibody Market
- 9.1. China Custom Antibody Market Overview
- 9.2. China Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Custom Antibody Market
- 10.1. India Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Custom Antibody Market
- 11.1. Japan Custom Antibody Market Overview
- 11.2. Japan Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Custom Antibody Market
- 12.1. Australia Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Custom Antibody Market
- 13.1. Indonesia Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Custom Antibody Market
- 14.1. South Korea Custom Antibody Market Overview
- 14.2. South Korea Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Custom Antibody Market
- 15.1. Western Europe Custom Antibody Market Overview
- 15.2. Western Europe Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Custom Antibody Market
- 16.1. UK Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Custom Antibody Market
- 17.1. Germany Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Custom Antibody Market
- 18.1. France Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Custom Antibody Market
- 19.1. Italy Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Custom Antibody Market
- 20.1. Spain Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Custom Antibody Market
- 21.1. Eastern Europe Custom Antibody Market Overview
- 21.2. Eastern Europe Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Custom Antibody Market
- 22.1. Russia Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Custom Antibody Market
- 23.1. North America Custom Antibody Market Overview
- 23.2. North America Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Custom Antibody Market
- 24.1. USA Custom Antibody Market Overview
- 24.2. USA Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Custom Antibody Market
- 25.1. Canada Custom Antibody Market Overview
- 25.2. Canada Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Custom Antibody Market
- 26.1. South America Custom Antibody Market Overview
- 26.2. South America Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Custom Antibody Market
- 27.1. Brazil Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Custom Antibody Market
- 28.1. Middle East Custom Antibody Market Overview
- 28.2. Middle East Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Custom Antibody Market
- 29.1. Africa Custom Antibody Market Overview
- 29.2. Africa Custom Antibody Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Custom Antibody Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Custom Antibody Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Custom Antibody Market Competitive Landscape And Company Profiles
- 30.1. Custom Antibody Market Competitive Landscape
- 30.2. Custom Antibody Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
31. Custom Antibody Market Other Major And Innovative Companies
- 31.1. Bio-Rad Laboratories Inc.
- 31.2. Bio-Techne Corporation
- 31.3. GenScript Biotech Corporation
- 31.4. BioLegend Inc.
- 31.5. Abcam plc
- 31.6. Cusabio Biotech Co. Ltd.
- 31.7. OriGene Technologies Inc.
- 31.8. Cell Signaling Technology Inc.
- 31.9. Abgent Inc.
- 31.10. ProSci Incorporated
- 31.11. Santa Cruz Biotechnology Inc.
- 31.12. Rockland Immunochemicals Inc.
- 31.13. Creative Biolabs Inc.
- 31.14. Novus Biologicals LLC
- 31.15. Creative Diagnostics Inc.
32. Global Custom Antibody Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Custom Antibody Market
34. Recent Developments In The Custom Antibody Market
35. Custom Antibody Market High Potential Countries, Segments and Strategies
- 35.1 Custom Antibody Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Custom Antibody Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Custom Antibody Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
